000 | 01366 a2200397 4500 | ||
---|---|---|---|
005 | 20250512083344.0 | ||
264 | 0 | _c19850812 | |
008 | 198508s 0 0 eng d | ||
022 | _a0730-0077 | ||
024 | 7 |
_a10.3109/10641968509077212 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKrzesinski, J M | |
245 | 0 | 0 |
_aThe erythrocyte sodium-potassium cotransport in hypertensive patients: advantages and limitations. _h[electronic resource] |
260 |
_bClinical and experimental hypertension. Part A, Theory and practice _c1985 |
||
300 |
_a553-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiological Transport, Active |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xblood |
650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMenstrual Cycle |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 |
_aPotassium _xblood |
650 | 0 | 4 |
_aSodium _xblood |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aRorive, G L | |
773 | 0 |
_tClinical and experimental hypertension. Part A, Theory and practice _gvol. 7 _gno. 4 _gp. 553-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10641968509077212 _zAvailable from publisher's website |
999 |
_c4011946 _d4011946 |